Skip to search.
 All Ordinaries Up 0.28%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
0.37 Down 0.01(3.92%) 02:26 - Nasdaq Real-Time Price
Prev Close:0.38
Open:0.37
Bid:0.37 x 45700
Ask:0.37 x 1400
1y Target Est:1.00
Beta:0.706707
Next Earnings Date:N/A
Day's Range:0.37 - 0.39
52wk Range:0.15 - 2.65
Volume:166,428
Avg Vol (3m):1,217,610
Market Cap:50.15M
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTADown 3.92%50.15M
INFIDown 0.77%255.15M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.07
Quarterly EPS Est (Jun-16) :-0.02
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp. focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its clinical stage drug candidate in oncology is ganetespib, an Hsp90 inhibitor, which is in Phase II clinical... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback